1.14 - 1.17
1.10 - 1.60
14.0K / 2.1K (Avg.)
-9.00 | -0.13
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-69.22%
Negative revenue growth while PGN.DE stands at 10.33%. Joel Greenblatt would look for strategic missteps or cyclical reasons.
51.02%
Gross profit growth above 1.5x PGN.DE's 5.14%. David Dodd would confirm if the company's business model is superior in terms of production costs or pricing.
-579.48%
Negative EBIT growth while PGN.DE is at 59.19%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
42.36%
Operating income growth at 50-75% of PGN.DE's 59.19%. Martin Whitman would doubt the firm’s ability to compete efficiently.
-543.23%
Negative net income growth while PGN.DE stands at 535.16%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-548.72%
Negative EPS growth while PGN.DE is at 600.00%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-548.72%
Negative diluted EPS growth while PGN.DE is at 600.00%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
101.79%
Similar OCF growth to PGN.DE's 107.30%. Walter Schloss would assume comparable operations or industry factors.
-96.42%
Negative FCF growth while PGN.DE is at 13.25%. Joel Greenblatt would demand improved cost control or more strategic capex discipline.
-54.47%
Both companies have negative long-term revenue/share growth. Martin Whitman would question if the entire market or product set is shrinking.
-54.47%
Negative 5Y CAGR while PGN.DE stands at 47.20%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
-54.47%
Negative 3Y CAGR while PGN.DE stands at 32.97%. Joel Greenblatt would look for missteps or fading competitiveness that hurt sales.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-265.42%
Both face negative decade-long net income/share CAGR. Martin Whitman would suspect a shrinking or highly disrupted sector.
-265.42%
Both exhibit negative net income/share growth over five years. Martin Whitman would suspect a challenging environment for the entire niche.
-265.42%
Both companies show negative 3Y net income/share growth. Martin Whitman suspects macro or sector-specific headwinds in the short run.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-101.16%
Both reduce receivables yoy. Martin Whitman suspects a shift in the entire niche’s credit approach or softer demand.
340.13%
Inventory growth well above PGN.DE's 1.24%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
-8.06%
Both reduce assets yoy. Martin Whitman suspects a broader sector retraction or post-boom asset trimming cycle.
-52.70%
Both erode book value/share. Martin Whitman suspects a difficult environment or poor capital deployment for both players.
19.06%
Debt growth far above PGN.DE's 3.25%. Michael Burry fears the firm is taking on undue leverage vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
66.15%
SG&A growth well above PGN.DE's 5.10%. Michael Burry sees potential margin erosion unless it translates into higher sales or brand equity.